Skyscape Web Viewer : Evidenced-Based Medicine Guidelines (EBMG) : Evidence summaries

View All
Behavioural Interventions for Primary and Secondary Dysmenorrhoea
Behavioural Treatments for Chronic Low Back Pain
Behavioural Versus other Psychological Therapies for Depression
Belimumab for Systemic Lupus Erythematosus
Bendamustine for Patients with Indolent B Cell Lymphoid Malignancies Including Chronic Lymphocytic Leukaemia
Benefit of Different Cholesterol-Lowering Interventions
Benzodiazepines Alone or in Combination with Antipsychotic Drugs for Acute Psychosis
Benzodiazepines for Alcohol Withdrawal
Benzodiazepines for Generalized Anxiety Disorder
Benzodiazepines for Neuroleptic-Induced Tardive Dyskinesia
Benzodiazepines for Schizophrenia
Benzodiazepine Use during Pregnancy and Congenital Malformations
Beta2-Agonists for Acute Bronchitis
Beta2-Agonists for Exercise-Induced Asthma
Beta-Adrenergic Blocking Agents and Intermittent Claudication
Beta-Blockers, Calcium Antagonists, or Nitrates for Stable Angina
Beta-Blockers after Acute Myocardial Infarction
Beta-Blockers Against other Antihypertensive Drugs
Beta-Blockers as Second-Line Therapy for Primary Hypertension
Beta-Blockers for Congestive Heart Failure in Children
Beta-Blockers for Essential Tremor
Beta-Blockers for Heart Failure
Beta-Blockers for Hypertension
Beta-Blockers for Hyperthyreoidism
Beta-Blockers for Mild to Moderate Hypertension in Pregnancy
Beta Blockers for Unstable Angina
Beta-Blockers in Patients Without Heart Failure after Myocardial Infarction
Beta-Blockers in the Prevention of Gastrointestinal Bleeding in Patients with Cirrhosis and Esophageal Varices
Beta-Blockers in the Prevention of Gastrointestinal Rebleeding in Patients with Cirrhosis
Betahistine for Ménière's Disease and Vertigo